Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 22
Gene Symbol: ABCB7
ABCB7
0.100 Biomarker group HPO
Entrez Id: 225
Gene Symbol: ABCD2
ABCD2
0.010 GeneticVariation group BEFREE Significant risk factors for stroke were: age, previous TIA, atrial fibrillation (AF), oral anticoagulant (OAC) treatment, hypertension treatment, and the ABCD2 items speech impairment, unilateral weakness, and diabetes mellitus. 27750222 2017
Entrez Id: 51
Gene Symbol: ACOX1
ACOX1
0.100 Biomarker group HPO
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.100 Biomarker group HPO
Entrez Id: 175
Gene Symbol: AGA
AGA
0.100 Biomarker group HPO
Entrez Id: 501
Gene Symbol: ALDH7A1
ALDH7A1
0.100 Biomarker group HPO
Entrez Id: 118429
Gene Symbol: ANTXR2
ANTXR2
0.010 Biomarker group BEFREE LFS compared to no stimulation and HFS, in the absence of l-dopa effect, significantly improved DDK and speech intelligibility for sentence, among patients with severe speech impairment. 31060986 2019
Entrez Id: 383
Gene Symbol: ARG1
ARG1
0.100 Biomarker group HPO
Entrez Id: 8289
Gene Symbol: ARID1A
ARID1A
0.010 GeneticVariation group BEFREE The mutations were associated with syndromic ID and speech impairment (severe/profound in SMARCB1, SMARCE1, and ARID1A mutations; variable in SMARCA4, SMARCA2, and ARID1B mutations), which was frequently accompanied by agenesis or hypoplasia of the corpus callosum. 23637025 2013
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.130 GeneticVariation group CLINVAR
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.130 GeneticVariation group BEFREE The mutations were associated with syndromic ID and speech impairment (severe/profound in SMARCB1, SMARCE1, and ARID1A mutations; variable in SMARCA4, SMARCA2, and ARID1B mutations), which was frequently accompanied by agenesis or hypoplasia of the corpus callosum. 23637025 2013
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.130 Biomarker group BEFREE Phenotype-genotype comparison of the translocation patient to seven unpublished patients with various sized deletions encompassing ARID1B confirms that haploinsufficiency of ARID1B is associated with CC abnormalities, intellectual disability, severe speech impairment, and autism. 21801163 2012
Entrez Id: 57492
Gene Symbol: ARID1B
ARID1B
0.130 GeneticVariation group BEFREE Taken together with published data, these results indicate that haploinsufficiency of the ARID1B gene, which encodes an epigenetic modifier of chromatin structure, is an important cause of CSS and is potentially a common cause of intellectual disability and speech impairment. 22426309 2012
Entrez Id: 84100
Gene Symbol: ARL6
ARL6
0.100 Biomarker group HPO
Entrez Id: 84100
Gene Symbol: ARL6
ARL6
0.100 CausalMutation group CLINVAR
Entrez Id: 427
Gene Symbol: ASAH1
ASAH1
0.100 Biomarker group HPO
Entrez Id: 171023
Gene Symbol: ASXL1
ASXL1
0.010 Biomarker group BEFREE a cohort study, comparing 10 PD patients with severe speech impairment (MDS-UPDRS item 3.1 ≥ 3) with 10 PD patients with mild speech impairment (MDS-UPDRS item 3.1 ≤ 2), all submitted to STN-DBS. 31060986 2019
Entrez Id: 148789
Gene Symbol: B3GALNT2
B3GALNT2
0.100 Biomarker group HPO
Entrez Id: 8815
Gene Symbol: BANF1
BANF1
0.010 Biomarker group BEFREE The clinical presentation overlaps with intellectual disability syndromes associated with other BAF subunits, such as Coffin-Siris and Nicolaides-Baraitser syndromes and includes prominent speech impairment, hypotonia, feeding difficulties, behavioral abnormalities, and dysmorphic features such as hypertrichosis, thick eyebrows, thin upper lip vermilion, and upturned nose. 30580808 2019
Entrez Id: 92482
Gene Symbol: BBIP1
BBIP1
0.100 Biomarker group HPO
Entrez Id: 582
Gene Symbol: BBS1
BBS1
0.100 Biomarker group HPO
Entrez Id: 79738
Gene Symbol: BBS10
BBS10
0.100 Biomarker group HPO
Entrez Id: 166379
Gene Symbol: BBS12
BBS12
0.100 Biomarker group HPO
Entrez Id: 583
Gene Symbol: BBS2
BBS2
0.100 Biomarker group HPO
Entrez Id: 585
Gene Symbol: BBS4
BBS4
0.100 Biomarker group HPO